MLKL and hepatocellular carcinoma: We hence applied specific inhibitors (Z-VAD-FMK, necrostatin, ferrostatin) towards different types of cell death to examine whether they were able to rescue PA-induced cell death in MLKL-deficient HCC cells, yet none of the inhibitors showed the apparent impact (Supplementary Fig. S3d).